This trial is testing whether an adapted form of dialectical behavioral therapy, which teaches patients skills to cope with emotional and physical symptoms, can help reduce psychological distress in metastatic lung cancer patients.
- Lung Cancer
5 Primary · 6 Secondary · Reporting Duration: Baseline, post-intervention, one month post-intervention (approximately week 0, week 18, week 12)
Awards & Highlights
2 Treatment Groups
LiveWell: A Dialectical Behavioral Therapy Skills Training Protocol
1 of 2
Dialectical Behavioral Therapy Skills Training
1 of 2
70 Total Participants · 2 Treatment Groups
Primary Treatment: Dialectical Behavioral Therapy Skills Training · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants have been recruited for this trial thus far?
"Affirmative, the clinicaltrials.gov data confirms that this trial is still welcoming applicants and was initially posted on May 18th 2022. This study has a need for 70 patients from 1 sites, with its information recently updated on June 14th 2022." - Anonymous Online Contributor
Are there still available openings for participants in this experiment?
"Correct. According to clinicaltrials.gov, recruitment is still ongoing for this trial which was initially posted on May 18th 2022 and latest updated June 14th 2022; 70 individuals are required from one location." - Anonymous Online Contributor
What outcome is this clinical experiment aiming to demonstrate?
"The goal of this investigation, which will be analysed over a 12 week period post-intervention is to assess its feasibility. Secondary objectives include an evaluation of emotional regulation via the Difficulties in Emotion Regulation Scale (DERS-18), fatigue using the Fatigue Symptom Inventory (FSI) and breathlessness with the Modified Medical Research Council Dyspnea Scale (MMRCDS)." - Anonymous Online Contributor